{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:01:32Z","timestamp":1790276492873,"version":"4.1.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":577,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001691","name":"JSPS","doi-asserted-by":"publisher","award":["JP18K09018"],"award-info":[{"award-number":["JP18K09018"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP18K09018"],"award-info":[{"award-number":["JP18K09018"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["asbmr.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Tumor-induced osteomalacia (TIO) is an acquired fibroblast growth factor 23 (FGF23)-related hypophosphatemic osteomalacia caused by phosphaturic mesenchymal tumors (PMTs) developed in the bone or soft tissue. Diagnostic delay should be addressed, and ideal techniques to localize PMTs and efficient treatment options should be explored to improve the outcomes of this rare disease. To clarify the detailed clinical course and outcomes of TIO patients, retrospective questionnaire surveys were conducted among physicians from the Japanese Society for Bone and Mineral Research (JSBMR) and the Japan Endocrine Society (JES). The primary survey collected the number of TIO patients between January 2007 and December 2018. The secondary survey aimed to obtain the detailed characteristics, laboratory data, and outcomes. Eighty-eight patients (52 males, mean: 52\u2009years old) were included, and 24 patients were clinically diagnosed with TIO without localized PMTs. The median duration from the onset to detection of high FGF23 levels was 3.4\u2009years, with 77 patients being initially misdiagnosed. Among the methods used to detect small, localized PMTs (\u226410\u2009mm), fluorine-18-fluorodeoxyglucose-positron emission tomography\/computed tomography and somatostatin receptor scintigraphy were less sensitive than somatostatin receptor positron emission tomography\/computed tomography (SRPET\/CT). Systemic venous sampling (SVS) of FGF23 was performed in 53 patients; among them, SVS was considered useful for detecting localized PMTs in 45 patients with diverse tumor sizes. Finally, 45 patients achieved biochemical remission by surgery, 39 patients continued pharmaceutical treatment, including burosumab (11 patients), and four patients died. These results encouraged us to further increase the awareness of TIO and to improve the accessibility of SRPET\/CT and SVS. Further evidence about the efficacy of new pharmaceutical treatments is awaited. \u00a9 2022 American Society for Bone and Mineral Research (ASBMR).<\/jats:p>","DOI":"10.1002\/jbmr.4620","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T06:14:20Z","timestamp":1656656060000},"page":"1479-1488","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Clinical Challenges in Diagnosis, Tumor Localization and Treatment of Tumor-Induced Osteomalacia: Outcome of a Retrospective Surveillance"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5450-2247","authenticated-orcid":false,"given":"Naoko","family":"Hidaka","sequence":"first","affiliation":[{"name":"Osteoporosis Center The University of Tokyo Hospital Tokyo Japan"},{"name":"Division of Nephrology and Endocrinology The University of Tokyo Hospital Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minae","family":"Koga","sequence":"additional","affiliation":[{"name":"Osteoporosis Center The University of Tokyo Hospital Tokyo Japan"},{"name":"Division of Nephrology and Endocrinology The University of Tokyo Hospital Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Kimura","sequence":"additional","affiliation":[{"name":"Toranomon Hospital Endocrine Center, Toranomon Hospital Tokyo Japan"},{"name":"Division of Nephrology and Endocrinology The University of Tokyo Hospital Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitomo","family":"Hoshino","sequence":"additional","affiliation":[{"name":"Osteoporosis Center The University of Tokyo Hospital Tokyo Japan"},{"name":"Division of Nephrology and Endocrinology The University of Tokyo Hospital Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9178-7846","authenticated-orcid":false,"given":"Hajime","family":"Kato","sequence":"additional","affiliation":[{"name":"Osteoporosis Center The University of Tokyo Hospital Tokyo Japan"},{"name":"Division of Nephrology and Endocrinology The University of Tokyo Hospital Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6583-0879","authenticated-orcid":false,"given":"Yuka","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"Osteoporosis Center The University of Tokyo Hospital Tokyo Japan"},{"name":"Division of Nephrology and Endocrinology The University of Tokyo Hospital Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Makita","sequence":"additional","affiliation":[{"name":"Osteoporosis Center The University of Tokyo Hospital Tokyo Japan"},{"name":"Division of Nephrology and Endocrinology The University of Tokyo Hospital Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaomi","family":"Nangaku","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Endocrinology The University of Tokyo Hospital Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Horiguchi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine Gunma University Graduate School of Medicine Maebashi Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Furukawa","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine Wakayama Medical University Wakayama Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keizo","family":"Ohnaka","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine Graduate School of Medical Sciences, Kyushu University Fukuoka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Inagaki","sequence":"additional","affiliation":[{"name":"Endocrine Center Okayama University Hospital Okayama Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Diabetology and Endocrinology Kanazawa Medical University Kahoku Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolism Fujita Health University Toyoake Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Toranomon Hospital Endocrine Center, Toranomon Hospital Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Fukumoto","sequence":"additional","affiliation":[{"name":"Fujii Memorial Institute of Medical Sciences, Institute of Advanced Medical Sciences, Tokushima University Tokushima Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Nakatani","sequence":"additional","affiliation":[{"name":"Department of Musculoskeletal Oncology National Cancer Center Hospital East Kashiwa Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4071-5372","authenticated-orcid":false,"given":"Nobuaki","family":"Ito","sequence":"additional","affiliation":[{"name":"Osteoporosis Center The University of Tokyo Hospital Tokyo Japan"},{"name":"Division of Nephrology and Endocrinology The University of Tokyo Hospital Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,11]]},"reference":[{"issue":"9","key":"2024012713551888300_jbmr4620-bib-0001","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1507\/endocrj.EJ15-0275","article-title":"Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment","volume":"62","author":"Endo","year":"2015","journal-title":"Endocr J"},{"issue":"3","key":"2024012713551888300_jbmr4620-bib-0002","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2024012713551888300_jbmr4620-bib-0003","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"2024012713551888300_jbmr4620-bib-0004","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","article-title":"Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia","volume":"87","author":"Yamazaki","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"17","key":"2024012713551888300_jbmr4620-bib-0005","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","article-title":"Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia","volume":"348","author":"Jonsson","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"2024012713551888300_jbmr4620-bib-0006","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0031-3955(05)70485-5","article-title":"New perspectives on the biology and treatment of X-linked hypophosphatemic rickets","volume":"44","author":"Carpenter","year":"1997","journal-title":"Pediatr Clin North Am"},{"issue":"1","key":"2024012713551888300_jbmr4620-bib-0007","doi-asserted-by":"crossref","first-page":"17044","DOI":"10.1038\/nrdp.2017.44","article-title":"Tumour-induced osteomalacia","volume":"3","author":"Minisola","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"2024012713551888300_jbmr4620-bib-0008","doi-asserted-by":"crossref","first-page":"116064","DOI":"10.1016\/j.bone.2021.116064","article-title":"Challenges in the management of tumor-induced osteomalacia (TIO)","volume":"152","author":"Brandi","year":"2021","journal-title":"Bone"},{"issue":"1","key":"2024012713551888300_jbmr4620-bib-0009","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s00223-020-00691-6","article-title":"Tumor-induced osteomalacia","volume":"108","author":"Florenzano","year":"2021","journal-title":"Calcif Tissue Int"},{"issue":"7","key":"2024012713551888300_jbmr4620-bib-0010","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1507\/endocrj.EJ16-0587","article-title":"The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases","volume":"64","author":"Feng","year":"2017","journal-title":"Endocr J"},{"issue":"10","key":"2024012713551888300_jbmr4620-bib-0011","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1210\/jc.2016-2052","article-title":"68Ga-DOTATATE for tumor localization in tumor-induced Osteomalacia","volume":"101","author":"El-Maouche","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2024012713551888300_jbmr4620-bib-0012","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1007\/s00259-018-3971-x","article-title":"Diagnostic performance and impact on patient management of 68Ga-DOTA-TOC PET\/CT for detecting osteomalacia-associated tumours","volume":"45","author":"Paquet","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2024012713551888300_jbmr4620-bib-0013","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/cen.12822","article-title":"Utility of Gallium-68 DOTANOC PET\/CT in the localization of tumour-induced osteomalacia","volume":"84","author":"Bhavani","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2024012713551888300_jbmr4620-bib-0014","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1365-2796.2010.02262.x","article-title":"Clinical utility of systemic venous sampling of FGF23 for identifying tumours responsible for tumour-induced osteomalacia","volume":"268","author":"Ito","year":"2010","journal-title":"J Intern Med"},{"issue":"6","key":"2024012713551888300_jbmr4620-bib-0015","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/jbmr.316","article-title":"Selective venous catheterization for the localization of phosphaturic mesenchymal tumors","volume":"26","author":"Andreopoulou","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2024012713551888300_jbmr4620-bib-0016","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/jbmr.1881","article-title":"Tumor localization and biochemical response to cure in tumor-induced osteomalacia","volume":"28","author":"Chong","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2024012713551888300_jbmr4620-bib-0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","article-title":"Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature","volume":"28","author":"Folpe","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"14","key":"2024012713551888300_jbmr4620-bib-0018","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMc2020399","article-title":"Targeted FGFR blockade for the treatment of tumor-induced osteomalacia","volume":"383","author":"Hartley","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"2024012713551888300_jbmr4620-bib-0019","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF03343720","article-title":"Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia","volume":"23","author":"Huang","year":"2000","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"2024012713551888300_jbmr4620-bib-0020","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.bone.2009.06.017","article-title":"Hypophosphatemia induced by intravenous administration of saccharated ferric oxide. another form of FGF23-related hypophosphatemia","volume":"45","author":"Shimizu","year":"2009","journal-title":"Bone"},{"issue":"6","key":"2024012713551888300_jbmr4620-bib-0021","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s00774-021-01250-1","article-title":"Clinical performance of a novel chemiluminescent enzyme immunoassay for FGF23","volume":"39","author":"Ito","year":"2021","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"2024012713551888300_jbmr4620-bib-0022","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00774-021-01258-7","article-title":"Performance evaluation of the new chemiluminescent intact FGF23 assay relative to the existing assay system","volume":"40","author":"Kato","year":"2022","journal-title":"J Bone Miner Metab"},{"issue":"2","key":"2024012713551888300_jbmr4620-bib-0023","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/1066896915617828","article-title":"FGF23-associated tumor-induced osteomalacia in a patient with small cell carcinoma: a case report and regulatory mechanism study","volume":"24","author":"Sauder","year":"2016","journal-title":"Int J Surg Pathol"},{"issue":"2","key":"2024012713551888300_jbmr4620-bib-0024","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s12020-017-1351-0","article-title":"Mineral metabolism abnormalities in patients with prostate cancer: a systematic case controlled study","volume":"59","author":"Minisola","year":"2018","journal-title":"Endocrine"},{"issue":"1","key":"2024012713551888300_jbmr4620-bib-0025","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13256-020-02381-1","article-title":"Neurofibromatosis type 1 associated with hypophosphatemic osteomalacia due to hypersecretion of fibroblast growth factor 23: a case report","volume":"14","author":"Obo","year":"2020","journal-title":"J Med Case Reports"},{"key":"2024012713551888300_jbmr4620-bib-0026","doi-asserted-by":"crossref","first-page":"115055","DOI":"10.1016\/j.bone.2019.115055","article-title":"Elevated FGF23 in a patient with hypophosphatemic osteomalacia associated with neurofibromatosis type 1","volume":"129","author":"Sahoo","year":"2019","journal-title":"Bone"},{"issue":"2","key":"2024012713551888300_jbmr4620-bib-0027","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1297\/cpe.29.69","article-title":"Malignant transformation of phosphaturic mesenchymal tumor: a case report and literature review","volume":"29","author":"Oyama","year":"2020","journal-title":"Clin Pediatr Endocrinol"},{"issue":"8","key":"2024012713551888300_jbmr4620-bib-0028","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1507\/endocrj.EJ15-0289","article-title":"Pathogenesis and diagnostic criteria for rickets and osteomalacia","volume":"62","author":"Fukumoto","year":"2015","journal-title":"Endocr J"},{"issue":"4","key":"2024012713551888300_jbmr4620-bib-0029","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/MNM.0000000000001163","article-title":"Performance of 68Ga-DOTA-SST PET\/CT, octreoscan SPECT\/CT and 18F-FDG PET\/CT in the detection of culprit tumors causing osteomalacia: a meta-analysis","volume":"41","author":"Jiang","year":"2020","journal-title":"Nucl Med Commun"},{"issue":"4","key":"2024012713551888300_jbmr4620-bib-0030","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/path.4465","article-title":"Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour","volume":"235","author":"Lee","year":"2015","journal-title":"J Pathol"},{"issue":"11","key":"2024012713551888300_jbmr4620-bib-0031","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/modpathol.2016.137","article-title":"Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors","volume":"29","author":"Lee","year":"2016","journal-title":"Mod Pathol"},{"issue":"23","key":"2024012713551888300_jbmr4620-bib-0032","doi-asserted-by":"crossref","first-page":"11418","DOI":"10.1073\/pnas.1815166116","article-title":"Activation of unliganded FGF receptor by extracellular phosphate potentiates proteolytic protection of FGF23 by its O-glycosylation","volume":"166","author":"Takashi","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2024012713551888300_jbmr4620-bib-0033","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jos.2019.02.005","article-title":"Infiltrative nature of tumor-induced osteomalacia lesions in bone: correlation between radiological and histopathological features","volume":"24","author":"Kobayashi","year":"2019","journal-title":"J Orthop Sci"},{"issue":"2","key":"2024012713551888300_jbmr4620-bib-0034","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/jbmr.4184","article-title":"Interim analysis of a phase 2 open-label trial assessing burosumab efficacy and safety in patients with tumor-induced osteomalacia","volume":"36","author":"Imanishi","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2024012713551888300_jbmr4620-bib-0035","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/jbmr.4233","article-title":"Burosumab for the treatment of tumor-induced osteomalacia","volume":"36","author":"Jan de Beur","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2024012713551888300_jbmr4620-bib-0036","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/thx.42.11.909","article-title":"Tumour induced hypophosphataemia associated with small cell carcinoma of the bronchus","volume":"42","author":"Banks","year":"1987","journal-title":"Thorax"},{"issue":"2","key":"2024012713551888300_jbmr4620-bib-0037","doi-asserted-by":"crossref","first-page":"275","DOI":"10.7326\/0003-4819-93-2-275","article-title":"Hypophosphatemic osteomalacia: association with prostatic carcinoma","volume":"93","author":"Lyles","year":"1980","journal-title":"Ann Intern Med"},{"issue":"3","key":"2024012713551888300_jbmr4620-bib-0038","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1210\/jc.2012-3473","article-title":"Oncogenic osteomalacia due to FGF23-expressing colon adenocarcinoma","volume":"98","author":"Leaf","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024012713551888300_jbmr4620-bib-0039","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s40200-019-00398-y","article-title":"Oncogenic osteomalacia and metastatic breast cancer: a case report and review of the literature","volume":"18","author":"Savva","year":"2019","journal-title":"J Diabetes Metab Disord"},{"issue":"2","key":"2024012713551888300_jbmr4620-bib-0040","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5414\/CN110242","article-title":"Hypophosphatemia and FGF23 tumor-induced osteomalacia in two cases of metastatic breast cancer","volume":"95","author":"Abramson","year":"2021","journal-title":"Clin Nephrol"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jbmr.4620","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jbmr.4620","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/37\/8\/1479\/55455685\/jbmr4620.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/37\/8\/1479\/55455685\/jbmr4620.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T11:09:16Z","timestamp":1710328156000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/37\/8\/1479-1488\/7516575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,6,11]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.4620","relation":{"has-review":[{"id-type":"doi","id":"10.1002\/JBMR.4620\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4620\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4620\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4620\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4620\/v2\/review1","asserted-by":"object"}]},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12,1]]},"published":{"date-parts":[[2020,12,1]]},"assertion":[{"value":"2022-03-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}